Redmile Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-155,000
Closed -$9.11M 66
2024
Q1
$9.11M Buy
+155,000
New +$9.11M 0.33% 61